The Role of Perirenal Fat As Predictor in Diabetic Nephropathy
ConditionDiabetic
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorAssiut University
About this trial
1 detect the relationship between perirenal fat thickness (PrFT) and estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes (T2DM).
2)Explored the relationship between PRF thickness and the onset and progression of albuminuria in patients with diabetes 3)Evaluate associations between obesity-related markers with albuminuria and advanced kidney disease in patients with type 2 diabetes mellitus (DM)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
patients with a history of malignancy and surgical trauma.
patients diagnosed with nondiabetic renal diseases
Patients with renal replacement therapy (renal transplant or dialysis patients), renal morphological abnormalities (difference in kidney length between the two cm, solitary kidney or multiple kidneys, congenital kidney abnormalities, polycystic kidney, and hydronephrosis), liver cirrhosis.
Insulin dependent diabetes
Trial population
Follow up patient is T2DM
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Sonar
DeviceAbdominal sonar
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
the thickness of preirenal fat in diabetic patients
Follow up the patient with sonar to detect early changes in perirenal fat in diabetic patient. perirenal fat is the thickness of the fat capsule along the long axis of the kidney, and pararenal fat was the thickness of the fat layer measured between the medial surface of abdominal muscle tissue and the renal fascia.
Time frame
BasalineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: